GLOBUS MEDICAL INC financial data

Symbol
GMED on NYSE
Location
Audubon, PA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 422% % 72%
Quick Ratio 167% % 84%
Debt-to-equity 16% % -39%
Return On Equity 12% % 386%
Return On Assets 11% % 428%
Operating Margin 16% % 148%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 135,253,051 shares -0.09%
Entity Public Float $6,600,000,000 USD -14%
Weighted Average Number of Shares Outstanding, Basic 135,215,000 shares -0.38%
Weighted Average Number of Shares Outstanding, Diluted 137,056,000 shares -0.58%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $2,938,931,000 USD 17%
Research and Development Expense $147,246,000 USD -10%
Operating Income (Loss) $479,816,000 USD 189%
Nonoperating Income (Expense) $125,252,000 USD 100%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $605,068,000 USD 401%
Income Tax Expense (Benefit) $67,200,000 USD 279%
Net Income (Loss) Attributable to Parent $537,868,000 USD 422%
Earnings Per Share, Basic 3.98 USD/shares 424%
Earnings Per Share, Diluted 3.92 USD/shares 423%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $526,156,000 USD -33%
Marketable Securities, Current $31,087,000 USD -71%
Accounts Receivable, after Allowance for Credit Loss, Current $678,938,000 USD 22%
Inventory, Net $759,277,000 USD 15%
Assets, Current $2,125,611,000 USD -2.4%
Deferred Income Tax Assets, Net $218,215,000 USD 132%
Property, Plant and Equipment, Net $564,452,000 USD 0.45%
Operating Lease, Right-of-Use Asset $63,786,000 USD 28%
Intangible Assets, Net (Excluding Goodwill) $745,064,000 USD -6.3%
Goodwill $1,435,033,000 USD 0.18%
Other Assets, Noncurrent $78,781,000 USD 4.9%
Assets $5,302,761,000 USD 0.97%
Accounts Payable, Current $98,852,000 USD 32%
Employee-related Liabilities, Current $167,105,000 USD 10%
Accrued Liabilities, Current $333,586,000 USD 28%
Contract with Customer, Liability, Current $27,655,000 USD 25%
Liabilities, Current $498,499,000 USD -42%
Deferred Income Tax Liabilities, Net $22,538,000 USD 202%
Operating Lease, Liability, Noncurrent $103,918,000 USD 24%
Other Liabilities, Noncurrent $21,343,000 USD -0.87%
Liabilities $729,511,000 USD -32%
Accumulated Other Comprehensive Income (Loss), Net of Tax $15,346,000 USD
Retained Earnings (Accumulated Deficit) $1,387,957,000 USD 20%
Stockholders' Equity Attributable to Parent $4,573,250,000 USD 9.5%
Liabilities and Equity $5,302,761,000 USD 0.97%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $177,300,000 USD 238%
Net Cash Provided by (Used in) Financing Activities $635,396,000 USD -449%
Net Cash Provided by (Used in) Investing Activities $131,385,000 USD
Common Stock, Shares Authorized 775,000,000 shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $323,172,000 USD -185%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $526,156,000 USD -33%
Deferred Tax Assets, Valuation Allowance $139,168,000 USD -24%
Deferred Tax Assets, Gross $559,470,000 USD 22%
Operating Lease, Liability $118,656,000 USD 26%
Depreciation $159,286,000 USD 18%
Payments to Acquire Property, Plant, and Equipment $36,103,000 USD 26%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $560,075,000 USD 427%
Lessee, Operating Lease, Liability, to be Paid $156,115,000 USD 20%
Property, Plant and Equipment, Gross $1,269,452,000 USD 15%
Operating Lease, Liability, Current $14,738,000 USD 44%
Lessee, Operating Lease, Liability, to be Paid, Year Two $21,147,000 USD 44%
Lessee, Operating Lease, Liability, to be Paid, Year One $22,512,000 USD 38%
Operating Lease, Weighted Average Discount Rate, Percent 0.077 pure 60%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $37,459,000 USD 3.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three $18,514,000 USD 38%
Unrecognized Tax Benefits $57,150,000 USD 1.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four $18,007,000 USD 56%
Operating Lease, Payments $5,623,000 USD 18%
Additional Paid in Capital $3,169,812,000 USD 4.6%
Amortization of Intangible Assets $118,194,000 USD -0.99%
Depreciation, Depletion and Amortization $66,074,000 USD 20%
Deferred Tax Assets, Net of Valuation Allowance $420,302,000 USD 52%
Share-based Payment Arrangement, Expense $49,779,000 USD -8.1%